Efficient and high quality cell line and process development is the critical first step in the development of a robust manufacturing process for expression of a therapeutic protein. FUJIFILM Diosynth Biotechnologies' scientists have researched the key components in the generation of a recombinant cell line, and as a result have created our new Apollo™ mammalian expression platform. Utilizing this platform will produce a high quality recombinant cell line to take your biopharmaceutical from pre-clinical through to commercial production - a cell line for life.